The medical report of the entrance of the Baldomero Cavalcanti de Oliveira prison, in, notes that it is able to maintain the treatment of the former president. The document, however, emphasizes the importance of observing the age of Collor and possible worsening in the psychiatric picture.
The notes were sent to the (Federal Supreme Court) on the night of Monday (28). The doctor Kênia Andrade answered him as soon as the former Mandanker entered the prison last Friday (25).
Kenya measured Collor’s blood pressure, oxygen saturation and heart rate – to find changes at the time of prison.
The former president reported making daily use of eight medicines. Four of them are antidepressants, and one treats Parkinson’s disease. Collor still uses medications to treat gastric ulcers and balance the blood cholesterol level.
The former president says using CPAP at night. It is a positive pressure apparatus used to treat breathing disorders of sleep.
“Such conditions referred to by the patient are subject to treatment and monitoring within the Alagoas prison system, as long as their particularities are observed as to the advanced age and the possible worsening in their framework for their psychiatric disorder report,” the doctor says in the report.
Collor’s defense asks the Supreme Court for the former president to serve his eight-year and ten months in. Lawyers say the politician is elderly (75 years) and treats Parkinson’s diseases, severe sleep apnea and bipolar affective disorder.
Collor denied in custody hearing to have health problems and take continuous use remedies. The defense, however, included medical reports in the court proceeding to prove that the former president needs special care.
This Tuesday (29),. Medical documents will be used to support the magistrate’s decision on the request for house arrest.
“In addition to the documents attached, I determine that the defense of the custodian, within 48 (forty -eight) hours, add the full exams performed, including images tests, as well as clarify the lack of exams performed from 2019 to 2022, indicative and related to Parkinson’s disease,” said Moraes.
